Stock listing
TSX:NVS Novartis AG Stock
Canadian listing (TSX) of Novartis AG · home listing SIX Swiss:NOVN
Follow Novartis AG into a list and get an email when it puts out news.
Share price · TSX:NVS
$32.32 CAD +0.31 (+1.0%)
Close on Nov 16, 2026
- Day range
- $32.32 – $32.55 CADNov 16, 2026
- Volume
- 421 sharesNov 16, 2026
- Market cap
- $265.0B CADAt the close on Nov 16, 2026 · price × 8.20B shares outstanding
- 52-week range
- $24.21 – $32.55 CADLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- $35,421 CADMedian day 300 shares · 14 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:NOVN · Home | 134.26 CHF | -1.50 (-1.1%) | 374,101 | 134.98 | 135.28 | 134.14 | 135.76 | Delayed 15+ min · 12:44 PM GMT+1, Nov 17, 2026 |
| NYSE:NVS | $160.20 USD | -0.30 (-0.2%) | 1,630,384 | $162.36 | $163.28 | $159.94 | $160.50 | Close on Nov 16, 2026 |
| OTC:NVSEF | $159.26 USD | -2.855 (-1.8%) | 403 | $165.52 | $165.52 | $159.26 | $162.12 | Close on Nov 16, 2026 |
| Frankfurt:NOTA | €145.00 EUR | +2.00 (+1.4%) | — | €145.00 | €145.00 | €145.00 | €143.00 | Close on Nov 16, 2026 |
| B3:N1VS34 | 93.42 BRL | +2.34 (+2.6%) | 49 | 92.85 | 93.69 | 91.08 | 91.08 | Close on Nov 16, 2026 |
| TSX:NVS | $32.32 CAD | +0.31 (+1.0%) | 421 | $32.55 | $32.55 | $32.32 | $32.01 | Close on Nov 16, 2026 |
| LSE:0K9E | $161.15 USD | +0.85 (+0.5%) | 993 | $160.99 | $163.99 | $160.99 | $160.30 | Close on Nov 16, 2026 |
| Stuttgart:NOT | €145.60 EUR | +0.12 (+0.1%) | — | €145.28 | €148.02 | €145.28 | €145.48 | Close on Nov 16, 2026 |
| Munich:NOT | €145.90 EUR | +0.96 (+0.7%) | — | €145.94 | €145.94 | €145.90 | €144.94 | Close on Nov 16, 2026 |
| Dusseldorf:NOT | €145.52 EUR | +0.04 (0.0%) | — | €145.52 | €145.52 | €145.52 | €145.48 | Close on Nov 16, 2026 |
| Stuttgart:NOTA | €144.00 EUR | -2.00 (-1.4%) | 70 | €146.00 | €147.00 | €143.00 | €146.00 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · TSX:NVS · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $31.85 | +0.05 | +0.2% | $31.44 | $31.88 | $31.44 | 500 | |
| $31.80 | +0.65 | +2.1% | $32.02 | $32.02 | $31.80 | 700 | |
| $31.15 | +0.02 | +0.1% | $31.15 | $31.15 | $31.15 | 0 | |
| $31.13 | -0.44 | -1.4% | $31.75 | $31.75 | $31.13 | 800 | |
| $31.57 | -0.32 | -1.0% | $31.57 | $31.57 | $31.57 | 0 | |
| $31.89 | +0.23 | +0.7% | $31.89 | $31.89 | $31.89 | 200 | |
| $31.66 | +0.90 | +2.9% | $31.79 | $31.79 | $31.66 | 7,900 | |
| $30.76 | -0.44 | -1.4% | $30.98 | $30.98 | $30.76 | 200 | |
| $31.20 | +0.80 | +2.6% | $31.00 | $31.20 | $30.68 | 1,900 | |
| $30.40 | +0.69 | +2.3% | $30.35 | $30.40 | $30.35 | 200 | |
| $29.71 | -0.99 | -3.2% | $30.00 | $30.00 | $29.71 | 500 | |
| $30.70 | +0.50 | +1.7% | $30.70 | $30.70 | $30.70 | 200 | |
| $30.20 | +0.20 | +0.7% | $30.20 | $30.20 | $30.20 | 0 | |
| $30.00 | +0.40 | +1.4% | $30.00 | $30.00 | $30.00 | 100 | |
| $29.60 | -0.12 | -0.4% | $29.60 | $29.60 | $29.60 | 0 | |
| $29.72 | -0.15 | -0.5% | $29.72 | $29.72 | $29.72 | 0 | |
| $29.87 | +0.62 | +2.1% | $29.86 | $29.99 | $29.86 | 700 | |
| $29.25 | +0.77 | +2.7% | $29.46 | $29.46 | $29.25 | 400 | |
| $28.48 | +0.03 | +0.1% | $28.48 | $28.48 | $28.48 | 0 | |
| $28.45 | +0.45 | +1.6% | $28.45 | $28.45 | $28.45 | 100 | |
| $28.00 | -0.77 | -2.7% | $28.00 | $28.00 | $28.00 | 300 | |
| $28.77 | +0.91 | +3.3% | $28.77 | $28.77 | $28.77 | 400 | |
| $27.86 | +0.06 | +0.2% | $27.90 | $27.90 | $27.86 | 200 | |
| $27.80 | +0.18 | +0.7% | $28.01 | $28.01 | $27.80 | 300 | |
| $27.62 | -0.17 | -0.6% | $27.56 | $27.62 | $27.56 | 300 | |
| $27.79 | -1.00 | -3.5% | $28.45 | $28.45 | $27.79 | 400 | |
| $28.79 | -0.07 | -0.2% | $28.79 | $28.79 | $28.79 | 300 | |
| $28.86 | -0.29 | -1.0% | $28.85 | $29.03 | $28.85 | 5,000 | |
| $29.15 | +0.40 | +1.4% | $28.98 | $29.15 | $28.98 | 600 | |
| $28.75 | +0.49 | +1.7% | $28.75 | $28.75 | $28.75 | 100 | |
| $28.26 | +0.17 | +0.6% | $28.51 | $28.51 | $28.19 | 700 | |
| $28.09 | +0.45 | +1.6% | $28.09 | $28.09 | $28.09 | 200 | |
| $27.64 | +0.04 | +0.1% | $27.64 | $27.64 | $27.64 | 0 | |
| $27.60 | +0.06 | +0.2% | $27.87 | $27.87 | $27.60 | 300 | |
| $27.54 | +0.38 | +1.4% | $27.54 | $27.54 | $27.54 | 700 | |
| $27.16 | -0.15 | -0.5% | $27.16 | $27.16 | $27.16 | 0 | |
| $27.31 | +0.34 | +1.3% | $27.36 | $27.36 | $27.31 | 700 | |
| $26.97 | -0.33 | -1.2% | $27.11 | $27.11 | $26.88 | 8,300 | |
| $27.30 | +0.42 | +1.6% | $27.62 | $27.64 | $27.11 | 9,500 | |
| $26.88 | +0.14 | +0.5% | $27.02 | $27.02 | $26.84 | 700 | |
| $26.74 | +0.06 | +0.2% | $26.75 | $26.84 | $26.73 | 1,300 | |
| $26.68 | +0.10 | +0.4% | $26.60 | $26.84 | $26.57 | 8,100 | |
| $26.58 | -4.76 | -15.2% | $27.01 | $27.04 | $26.50 | 8,000 | |
| $31.34 | -0.09 | -0.3% | $31.34 | $31.34 | $31.34 | 0 | |
| $31.43 | +0.02 | +0.1% | $31.24 | $31.43 | $31.24 | 4,300 | |
| $31.41 | +0.16 | +0.5% | $31.40 | $31.41 | $31.14 | 800 | |
| $31.25 | +1.79 | +6.1% | $31.22 | $31.29 | $31.08 | 1,700 | |
| $29.46 | +0.01 | 0.0% | $29.46 | $29.46 | $29.46 | 1,000 | |
| $29.45 | -0.96 | -3.2% | $29.65 | $29.65 | $29.45 | 300 | |
| $30.41 | 0.00 | 0.0% | $30.41 | $30.41 | $30.41 | 0 | |
| $30.41 | -0.04 | -0.1% | $30.50 | $30.50 | $30.35 | 2,400 | |
| $30.45 | +0.08 | +0.3% | $30.45 | $30.45 | $30.45 | 100 | |
| $30.37 | +0.60 | +2.0% | $30.37 | $30.37 | $30.37 | 0 | |
| $29.77 | -0.11 | -0.4% | $29.77 | $29.77 | $29.77 | 0 | |
| $29.88 | -0.23 | -0.8% | $29.88 | $29.88 | $29.88 | 100 | |
| $30.11 | +0.75 | +2.6% | $30.11 | $30.11 | $30.11 | 300 | |
| $29.36 | +0.13 | +0.4% | $29.36 | $29.36 | $29.36 | 0 | |
| $29.23 | -0.18 | -0.6% | $29.23 | $29.23 | $29.23 | 0 |
- Ticker
- TSX:NVS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- TSX
- Currency
- CAD
What changed lately
Latest news release · Nov 17, 2026
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
Latest earnings call · Oct 27, 2026
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 91 slides
Calls
Replays
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Tue, Oct 27, 2026 · 7:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q2 2026 Earnings Call
Tue, Jul 21, 2026 · 8:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
Oct 27, 2026
Closed $31.20 (+2.6%) on Oct 27, 2026
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Oct 23, 2026
Closed $29.71 (-3.2%) on Oct 23, 2026
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
Oct 21, 2026
Closed $30.20 (+0.7%) on Oct 21, 2026
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
Oct 7, 2026
Closed $28.77 (+3.3%) on Oct 7, 2026
CAS ประกาศความร่วมมือกับ Novartis เพื่อขับเคลื่อนระบบข้อมูลด้านปฏิกิริยาเคมีที่พร้อมรองรับ AI
Sep 29, 2026
Closed $28.86 (-1.0%) on Sep 29, 2026
Issued by another party
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Sep 18, 2026
Closed $27.54 (+1.4%) on Sep 18, 2026
Sironax Announces Option Exercise and Asset Purchase
Sep 16, 2026
Closed $27.31 (+1.3%) on Sep 16, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 91 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 46 slides · Oct 23, 2026
Q2 2026 Earnings Presentation
Earnings · 87 slides · Jul 21, 2026
Q1 2026 Earnings Presentation
Earnings · 85 slides · Apr 28, 2026
Novartis AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 84 in the last 12 months · 117 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 26 calls with a replay · 26 with a transcript · latest Oct 27, 2026
- Decks
- 186 decks · latest Oct 27, 2026
Where Novartis AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:NOVN · Home listing | SIX Swiss | Switzerland | CHF |
| NYSE:NVS | NYSE | United States | USD |
| Xetra:NOT | Xetra | Germany | EUR |
| gettex:NOT | gettex | Germany | EUR |
| OTC:NVSEF | OTC | United States | USD |
| Tradegate:NOT | Tradegate | Germany | EUR |
| Milan:1NOVN | Milan | Italy | EUR |
| BCBA:NVS | BCBA | Argentina | ARS |
| LSIN:0QLR | LSIN | United Kingdom | CHF |
| gettex:NOTA | gettex | Germany | EUR |
| LS Exchange:904278 | LS Exchange | Germany | EUR |
| SIX Swiss:NOVNEE | SIX Swiss | Switzerland | CHF |
| BX Swiss:NOT | BX Swiss | Switzerland | CHF |
| Frankfurt:NOT | Frankfurt | Germany | EUR |
| Frankfurt:NOTA | Frankfurt | Germany | EUR |
| VIE:NOVN | Vienna | Austria | EUR |
| B3:N1VS34 | B3 | Brazil | BRL |
| Tradegate:NOTA | Tradegate | Germany | EUR |
| TSX:NVS · This page | TSX | Canada | CAD |
| Lang & Schwarz:904278 | Lang & Schwarz | Germany | EUR |
| Aquis:NOVNZ | Aquis | United Kingdom | CHF |
| Cboe Canada:NOVN | Cboe Canada | Canada | CAD |
| LSE:0K9E | LSE | United Kingdom | USD |
| Cboe Canada:NVS | Cboe Canada | Canada | CAD |
| Stuttgart:NOT | Stuttgart | Germany | EUR |
| BCBA:NVSD | BCBA | Argentina | USD |
| Munich:NOT | Munich | Germany | EUR |
| LS Exchange:907122 | LS Exchange | Germany | EUR |
| BMV:NVSN | BMV | Mexico | MXN |
| BCBA:NVSC | BCBA | Argentina | USD |
| BMV:NOVNN | BMV | Mexico | MXN |
| Hamburg:NOT | Hamburg | Germany | EUR |
| BOATS:NVS | BOATS | United States | USD |
| Dusseldorf:NOT | Dusseldorf | Germany | EUR |
| BCBA:NVSB | BCBA | Argentina | ARS |
| Stuttgart:NOTA | Stuttgart | Germany | EUR |
| Dusseldorf:NOTA | Dusseldorf | Germany | EUR |
| Hanover:NOT | Hanover | Germany | EUR |
| Frankfurt:NOT1 | Frankfurt | Germany | EUR |
| Turquoise:NOVNZ | Turquoise | United Kingdom | CHF |
| BIVA:NOVNN | BIVA | Mexico | MXN |
| Lang & Schwarz:907122 | Lang & Schwarz | Germany | EUR |
| Munich:NOTA | Munich | Germany | EUR |
| Frankfurt:NOT0 | Frankfurt | Germany | EUR |
| Hamburg:NOTA | Hamburg | Germany | EUR |
| BCBA:NVS.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Novartis AG.